Sterilex
Innovative Solutions for Microbial Control
Innovative Solutions for Microbial Control
Sterilex: Innovative Solutions for Microbial Control
Sterilex, a biotechnology company founded in 1994 and headquartered in the United States, is a recognized leader in developing antimicrobial, anti-biofilm, and decontamination products for various industries including animal health, food processing, water care, industrial processing, and environmental remediation.
The company's patented platform technology, PerQuat® technology, is a unique alkaline peroxygen phase-transfer chemistry that can effectively penetrate and remove biofilms, kill microorganisms, and remove organic and chemical contaminants, including nerve agents, organophosphorus pesticides, and carbamates.
Sterilex received a Private Equity Round investment on 27 April 2021 from Paine Schwartz Partners.
With its innovative solutions for microbial control and a focus on multiple industries, Sterilex continues to be a promising player in the biotechnology, healthcare, and pharmaceutical sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
27 Apr 2021 |
No recent news or press coverage available for Sterilex.
We care about your data, and we'd love to use cookies make your experience better.
